$25 is about $2b. Mesoblast's market cap is nearly this much...

$25 is about $2b. Mesoblast's market cap is nearly this much with nothing in commercialisation and were nearly worth $4b a couple of years ago. Alnylam too are hovering around $4b.

We could certainly be at $25 if there is any indication that tt-034 is working. However, we need a partner, or to IPO Tacere to have the cash to progress beyond PI/II. I think we could easily raise $100m if early efficacy comes back OK.

And if we commercialise, the company could easily be worth $20b or $250 per share.

But, lets not get ahead of ourselves. Ha!